首页 | 本学科首页   官方微博 | 高级检索  
     

西地那非治疗小儿肺动脉高压疗效观察
引用本文:潘筱,徐同芬,孙胜涛,马云霞. 西地那非治疗小儿肺动脉高压疗效观察[J]. 中国临床实用医学, 2010, 4(3): 109-110
作者姓名:潘筱  徐同芬  孙胜涛  马云霞
作者单位:山东省临沂市人民医院,276000
摘    要:西地那非是一种具有高度选择性的磷酸二酯酶抑制剂,通过抑制第二信使cGMP的代谢,发挥其治疗作用。研究表明西地那非口服对多种类型的肺动脉高压具有较高疗效,且价格相对便宜,因此其治疗前景是令人鼓舞的。但对原发性心肌病及未根治的先天性心脏病效果不十分理想。

关 键 词:西地那非  肺动脉高压  磷酸二酯酶抑制剂

Efficacy of sildenafil in children with pulmonary hypertension
Affiliation:PAN Xiao , XU Tong fen, SUN Sheng-tao , et al. (People's Hospital Of Linyi City In ShanDong Province,Linyi 276000, China)
Abstract:Sildenafil is a highly selective inhibitor of phosphodiesterase, it plays by inhibiting cGMP.The subject Showed that oral Sildenafil had signifant effect to many kind of pulmonary hypertension. In the other hand, sildenafil is expensive comparely, so it is a bright tomorrow. But it has only low effect to myocarditis and CHD without treatment.
Keywords:Sildenafil  Pulmonary hypertension  Inhibitor of phosphodiesterase
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号